Noetik Secures $40 Million in Series A Funding to Revolutionize Cancer Therapeutics

Noetik, a pioneering AI-native biotechnology firm dedicated to advancing precision cancer therapies, has successfully closed a substantial $40 million Series A financing round. This oversubscribed round was spearheaded by Polaris Partners, with Amy Schulman, Managing Partner, joining Noetik’s board of directors. The funding also saw participation from notable new investors including Khosla Ventures, Wittington Ventures,…

Read More

Codeium Achieves $1.25 Billion Valuation with $150 Million Series C Funding Led by General Catalyst

Codeium, a leading generative AI-powered coding platform, has announced the successful closure of a $150 million Series C funding round, elevating the company’s valuation to an impressive $1.25 billion. This funding round was spearheaded by General Catalyst, with continued backing from existing investors Kleiner Perkins and Greenoaks. With this new capital, Codeium solidifies its position…

Read More

Innovating the Future of Tech: Revolka Co., Ltd. Pioneers New Solutions in AI and Robotics

RevolKa Ltd. a pioneering biotech firm at the forefront of AI-driven protein engineering, proudly announces the successful closure of its Series A extension funding, raising a total of 250 million JPY (approximately US$1.7 million). This latest infusion of capital, which includes a 100 million JPY (US$0.7 million) financing round, is poised to significantly enhance RevolKa’s…

Read More